Salicylate poisoning: An evidence-based consensus guideline for out-of-hospital management

Abstract

American Association of Poison Control Centers, Washington, District of Columbia, USAA review of U.S. poison center data for 2004 showed over 40,000 exposures to salicylate-containing products. A guideline that determines the conditions for emergency department referral and pre-hospital care could potentially optimize patient outcome, avoid unnecessary emergency department visits, reduce health care costs, and reduce life disruption for patients and caregivers. An evidence-based expert consensus process was used to create the guideline. Relevant articles were abstracted by a trained physician researcher. The first draft of the guideline was created by the lead author. The entire panel discussed and refined the guideline before distribution to secondary reviewers for comment. The panel then made changes based on the secondary review comments. The objective of this guideline is to assist poison center personnel in the appropriate out-of-hospital triage and initial out-of-hospital management of patients with a suspected exposure to salicylates by 1) describing the process by which a specialist in poison information should evaluate an exposure to salicylates, 2) identifying the key decision elements in managing cases of salicylate exposure, 3) providing clear and practical recommendations that reflect the current state of knowledge, and 4) identifying needs for research. This guideline is based on an assessment of current scientific and clinical information. The expert consensus panel recognizes that specific patient care decisions may be at variance with this guideline and are the prerogative of the patient and the health professionals providing care, considering all of the circumstances involved. This guideline does not substitute for clinical judgment. Recommendations are in chronological order of likely clinical use. The grade of recommendation is in parentheses: 1) Patients with stated or suspected self-harm or who are the victims of a potentially malicious administration of a salicylate, should be referred to an emergency department immediately. This referral should be guided by local poison center procedures. In general, this should occur regardless of the dose reported (Grade D).2) The presence of typical symptoms of salicylate toxicity such as hematemesis, tachypnea, hyperpnea, dyspnea, tinnitus, deafness, lethargy, seizures, unexplained lethargy, or confusion warrants referral to an emergency department for evaluation (Grade C). 3) Patients who exhibit typical symptoms of salicylate toxicity or nonspecific symptoms such as unexplained lethargy, confusion, or dyspnea, which could indicate the development of chronic salicylate toxicity, should be referred to an emergency department (Grade C). 4) Patients without evidence of self-harm should have further evaluation, including determination of the dose, time of ingestion, presence of symptoms, history of other medical conditions, and the presence of co-ingestants. The acute ingestion of more than 150 mg/kg or 6.5 g of aspirin equivalent, whichever is less, war...

An effective antidote for paraquat poisonings: The treatment with lysine acetylsalicylate

“…In the LAS formulation, 1.8 g of powder prepared by lyophilization is equivalent to 1 g of ASA. ASA, LAS and other acetylsalicylate derivatives can be detected in the plasma only for a short period of time as result of its hydrolysis by carboxylesterases to SAL in plasma, liver, and erythrocytes (Needs and Brooks, 1985;Ulrich et al, 2006;Chyka et al, 2007). Due to this rapid deacetylation, it has been assumed that anti-inflammatory effects of acetylsalicylate derivatives are largely mediated by SAL (Higgs et al, 1987).…”

Pharmacologic Strategies for Treatment of Poisonings

“…18 The serum half-life of salicylates is typically 2 to 4 hours in low doses and as much as 12 hours when taken in higher doses. 19 Signs and symptoms are dose and time dependent. Early signs include nausea and vomiting related to GI tract irritation.…”

A Serious Diagnosis often Missed: Salicylate Induced Pulmonary Edema (SIPE)

“…A recent guideline by the American Association of Poison Control Centers suggest acute toxicity as ingestion of less than eight hours and chronic as longer than this duration [6].…”